Agouron and immune response to commercialize remune immune-based treatment.
James
J S
JS
D016915:AIDS Vaccines / Q000627:therapeutic use*; D015415:Biomarkers; D017326:Clinical Trials, Phase III as Topic; D004345:Drug Industry; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D014481:United States
D016915:AIDS Vaccines; D015415:Biomarkers